September 2026
The respiratory antiviral treatment market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 128.39 billion in 2026 with a CAGR of 6.07%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global cardiorespiratory assessment units market size was evaluated at USD 1.56 billion in 2026 and is predicted to hit around USD 3.00 billion by 2035, growing at a CAGR of 7.55%.
September 2026
The respiratory syncytial virus diagnostic market size stood at USD 1.67 billion in 2026, with major Abbott Laboratories, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company (BD), Danaher Corporation (Cepheid) companies including respiratory syncytial virus diagnostic market.
September 2026
The global anesthesia and respiratory devices market size is projected to hit around USD 95.26 billion by 2035 from USD 53.73 billion in 2026, with a CAGR of 6.56%.
September 2026
The tendonitis treatment market size was calculated at USD 249.63 billion in 2026 and is projected to hit around USD 340.22 billion by 2035 with a CAGR of 3.50%.
September 2026
The substance abuse treatment market size is expected to increase from USD 36.83 billion by 2034 from USD 17.23 billion in 2026 with a solid CAGR of 10.05%.
September 2026
The global oral mucositis treatment market size is estimated to hit around USD 3.96 billion by 2035 increasing from USD 2.13 billion in 2026, with a CAGR of 7.12%.
September 2026
The global respiratory monitoring devices market size is projected to hit around USD 39.72 billion by 2035 from USD 18.44 billion in 2026 with a CAGR of 8.96%.
September 2026
The ear nose throat (ENT) treatment market size was estimated to hit around USD 35.15 billion by 2035 increasing from USD 21.10 billion in 2026, with a CAGR of 5.82%.
September 2026
The global mouth ulcer treatment market size was calculated at USD 1.75 billion in 2026 and is expected to worth around USD 2.46 billion by 2035 with a CAGR of 3.89%.
September 2026
The global osteoporosis treatment market size is accounted at USD 14.10 billion in 2026 and is projected to hit around USD 21.79 billion by 2035 with a CAGR of 4.96%.
September 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 4.35 billion in 2026 with a CAGR of 15.48%.
September 2026
The global seed treatment market size is calculated at USD 19.65 billion in 2026 and is projected to hit around USD 42.02 billion by 2035 with a notable CAGR of 8.83%.
September 2026
The hemophilia treatment market was valued at USD 23.23 billion in 2026, with leading companies including Shire, CSL Behring, Grifols, S.A., Biogen Inc..
September 2026
The biological treatment technologies market was valued at USD 3.34 billion in 2026, with leading companies including Scarab International, Alfa Laval, Pentair PLC, Evoqua Water Technology.
September 2026
The global amblyopia treatment market size was valued at USD 4.37 billion in 2026 and is projected to attain around USD 5.88 billion by 2034 with a CAGR of 3.80%.
September 2026
The global addiction treatment market size was valued at USD 10.53 billion in 2026 and is expected to hit around USD 16.22 billion by 2034, growing at a CAGR of 5.56%.
September 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
September 2026
The global chronic venous occlusions treatment market size is estimated to surge around USD 11.52 billion by 2035 increasing from USD 7.77 billion in 2026, with a CAGR of 4.47%.
September 2026
The global medical adhesive-related skin injury (MARSI) treatment market size is estimated to hit around USD 947.16 million by 2035 increasing from USD 526.90 million in 2025, with a CAGR of 6.04%.
September 2026
The global adhesive capsulitis treatment market size was evaluated at USD 1.37 billion in 2026 and is predicted to hit around USD 2.13 billion by 2035, growing at a CAGR of 5.05%.
September 2026
The global systemic inflammatory response syndrome treatment market size is estimated to hit around USD 25.84 billion by 2035 increasing from USD 16.02 billion in 2026, with a CAGR of 5.98%.
September 2026
The global scar treatment market size was calculated at USD 35.65 billion in 2026 and is projected to hit around USD 81.98 billion by 2035 with a soild CAGR of 9.77%.
September 2026
The psoriatic arthritis treatment market size was valued at USD 14.17 billion in 2026 and is expected to hit around USD 25.89 billion by 2034 with a CAGR of 7.83%.
September 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
September 2026
The global respiratory protective equipment market size is expected to hit around USD 32.12 billion by 2034 from USD 19.38 billion in 2026 with a CAGR of 6.53%.
September 2026
The global rotator cuff injury treatment market size was evaluated at USD 1.47 billion in 2026 and is predicted to hit around USD 2.35 billion by 2035, growing at a CAGR of 5.37%.
September 2026
The sludge treatment chemicals market reached USD 8.47 billion in 2026, with key sludge treatment chemicals companies including kemira oyj, ecolab inc, basf se, accepta ltd, snf group.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com